Details

Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Processus d’examen, communications et transparence - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 13, 2026 · edition #6
Timestamp: 2026-04-13T10:26:02.451Z
Language: fr
Original URL: https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/processus-examen-communications-transparence.html
Replay URL: https://replay.healtharchive.ca/job-6/20260413102602/https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/processus-examen-communications-transparence.html#ha_snapshot=386076
ID: 386076
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots